---
title: "SENSSUN shareholder Zhao Yukun plans to reduce his holdings by no more than 3%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256263030.md"
description: "According to the Zhitong Finance APP, SENSSUN announced that the company's shareholder Mr. Zhao Yukun intends to reduce his holdings of the company's shares by no more than 3.915 million shares (accounting for 3% of the total share capital after excluding the company's repurchase special account) through centralized bidding and block trading from September 29, 2025, to December 28, 2025"
datetime: "2025-09-07T09:11:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256263030.md)
  - [en](https://longbridge.com/en/news/256263030.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256263030.md)
generator: "portal-rs"
---

# SENSSUN shareholder Zhao Yukun plans to reduce his holdings by no more than 3%

According to the Zhitong Finance APP, SENSSUN (002870.SZ) announced that the company's shareholder Mr. Zhao Yukun intends to reduce his holdings of the company's shares by no more than 3.915 million shares (accounting for 3% of the total share capital after excluding the company's repurchase special account) through centralized bidding and block trading from September 29, 2025, to December 28, 2025

### Related Stocks

- [002870.CN](https://longbridge.com/en/quote/002870.CN.md)

## Related News & Research

- [Shein’s Hong Kong IPO pricing values company at US$26.5b: sources](https://longbridge.com/en/news/297156490.md)
- [REG - AIM - AIM Notice - 28/08/2026](https://longbridge.com/en/news/297278146.md)
- [Why You Might Be Interested In Alivus Life Sciences Limited (NSE:ALIVUS) For Its Upcoming Dividend](https://longbridge.com/en/news/297244607.md)
- [REG - Societe Generale SA Spire Healthcare Grp - Form 8.3 - Spire Healthcare Group plc](https://longbridge.com/en/news/297185849.md)
- [Finance Magnates Summit London Returns to Old Billingsgate for its Landmark 15th Edition](https://longbridge.com/en/news/297161954.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**